Radiopharm Theranostics
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - non WALists and Charts
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 839th |  | Radiopharm Theranostics | $6.2m |
| 863rd | | Future First Technologies | $4.9m |
| 864th | | Chimeric Therapeutics | $4.9m |
| 866th |  | DGO Gold | $4.8m |
| 867th | | Actinogen Medical | $4.8m |
1329 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 31/10/23
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1192nd | Radiopharm Theranostics | -30% | |
| 1714th | Chimeric Therapeutics | -64% | |
| 1921st | Actinogen Medical | -86% | -18% |
1838 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
 | NEWS: Tagged in Tax rebate to help Radiopharm diagnose, treat cancers | 21 Nov 2023 |
| NEW ROLE: Thomas Tulip, | 30 Oct 2023 |
| NEWS: Tagged in Radiopharm trials to lift pancreatic cancer hopes | 17 Oct 2023 |
| NEWS: Tagged in Radiopharm green-lighted for radioactive lung cancer trial | 09 Oct 2023 |
| NEWS: Tagged in Radiopharm inks new deal in fight against prostate cancer | 24 Aug 2023 |
| NEWS: Tagged in Radiopharm gets big boost for brain cancer trials bid | 29 May 2023 |
| NEWS: Tagged in Radiopharm secures US approval for second cancer treatment | 09 May 2023 |
| NEWS: Tagged in Radiopharm targets “first-in-class” brain cancer treatment | 17 Apr 2023 |
